Get the Stockscreener App
3.12
1.58%
-0.05
After Hours:
3.23
0.11
+3.53%
Nrx Pharmaceuticals Inc stock is traded at $3.12, with a volume of 311.79K.
It is down -1.58% in the last 24 hours and up +11.43% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$3.17
Open:
$3.24
24h Volume:
311.79K
Relative Volume:
0.81
Market Cap:
$61.81M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.78
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
-6.87%
1M Performance:
+11.43%
6M Performance:
+52.20%
1Y Performance:
+127.74%
1-Day Range:
$3.10
$3.24
1-Week Range:
$3.10
$3.84
52-Week Range:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.12 | 75.35M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | H.C. Wainwright | Buy |
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
What earnings revisions data tells us about NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Technical signs of recovery in NRx Pharmaceuticals Inc.2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Will a bounce in NRx Pharmaceuticals Inc. Equity Warrant offer an exitWeekly Market Report & Safe Entry Point Alerts - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock go up soon2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upsidePortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stockPortfolio Return Report & Smart Money Movement Alerts - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. Equity Warrant with statistical toolsJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
What does recent volatility data suggest for NRx Pharmaceuticals Inc. Equity WarrantGap Down & Weekly Return Optimization Plans - newser.com
Live market analysis of NRx Pharmaceuticals Inc. Equity WarrantTrade Risk Report & Daily Price Action Insights - newser.com
Will NRx Pharmaceuticals Inc. stock gain from government policiesJuly 2025 PreEarnings & Growth Focused Entry Point Reports - newser.com
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Columbia Daily Tribune
Combining machine learning predictions for NRx Pharmaceuticals Inc.2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
Will NRx Pharmaceuticals Inc. Equity Warrant outperform the marketOptions Play & Scalable Portfolio Growth Ideas - newser.com
NRx Pharmaceuticals Inc. stock trend forecastJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock could outperform in 20252025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Earnings visualization tools for NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
Why NRx Pharmaceuticals Inc. Equity Warrant stock is seen as undervaluedJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Applying Elliott Wave Theory to NRx Pharmaceuticals Inc. Equity WarrantMarket Rally & AI Driven Price Predictions - newser.com
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - The Register-Guard
Is NRx Pharmaceuticals Inc. Equity Warrant forming a reversal pattern2025 Dividend Review & Safe Capital Investment Plans - newser.com
NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies - NewMediaWire
NRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based Therapies - TipRanks
Is NRx Pharmaceuticals Inc. Equity Warrant stock bottoming outOptions Play & Expert-Curated Trade Recommendations - newser.com
How to build a dashboard for NRx Pharmaceuticals Inc. Equity Warrant stockQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
What drives CAMP stock priceShort Interest Overview & Free Hedging Tactics for Volatile Markets - earlytimes.in
NRX Pharmaceuticals at Noble Capital Markets: Pioneering Mental Health Solutions - Investing.com Canada
Oklahoma City NewsThe Oklahoman - FinancialContent
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference - Sahm
NRx Pharmaceuticals (NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference - NewMediaWire
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference - TipRanks
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):